CoverageForm 410-K10-Q8-K13D13G13F

LPTX Leap Therapeutics, Inc. - 8-K

Filed Mar 16, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001104659-26-028558
2.029.01

Item 2.02 - Results of Operations and Financial Condition

Earnings press release item. The actual results are typically in Exhibit 99.1 - fetch may not have completed.

Item 2.02.

Results of Operations and Financial Condition

On March 16, 2026, Cypherpunk Technologies Inc.
(the “Company”) announced its financial results for the year ended December 31, 2025.  The full text of the press release
issued by the Company in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained herein and in the accompanying
exhibit shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless
of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information
in this Current Report on Form 8-K, including the information set forth under this Item 2.02 and the exhibit hereto, shall not be deemed
to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.

Item 9.01 - Financial Statements and Exhibits

34 words

Item 9.01.

Financial Statements and Exhibits.

(d)       Exhibits.

Exhibit

Number

Description

99.1

Press Release of Cypherpunk Technologies Inc. dated March 16, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).